Lou Arcudi

Lou Arcudi has had a diverse and extensive work experience. Currently, they serve as the Chief Financial Officer at Amolyt Pharma, where they are involved in developing life-changing treatments for patients with rare endocrine and metabolic diseases. Prior to this role, they were the President and CEO at MILLENDO THERAPEUTICS and previously held the position of CFO at the same company. Lou also served as the CFO & SVP of Operations at Idera Pharmaceuticals and held the role of Prior Chairman at ABFO. Their earlier experiences include serving as the SVP of Finance & Operations at Peptimmune, the Director of International Finance and Commercial Operations at Genzyme, and the International Finance Manager at Cognex Corporation.

Lou Arcudi attended Milford High School, where they completed their secondary education. Lou then went on to Southern New Hampshire University from 1978 to 1982, where they obtained a Bachelor of Science (BS) degree in Business. In 1983, they attended Babson College, earning a Certificate in International Studies. Continuing their education, Lou enrolled at Bryant University from 1984 to 1987, where they pursued a Master of Business Administration (MBA) degree with a focus in Finance.